Case report of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
10.3760/cma.j.cn101070-20190621-00559
- VernacularTitle:线粒体3-羟基-3-甲基戊二酰辅酶A合成酶缺乏症1例
- Author:
Haijun WANG
1
;
Dongxiao LI
;
Chunlan SONG
;
Yanling YANG
;
Suyun QIAN
;
Yibing CHENG
Author Information
1. 郑州大学附属儿童医院，河南省儿童医院急诊科 450000
- From:
Chinese Journal of Applied Clinical Pediatrics
2020;35(16):1269-1271
- CountryChina
- Language:Chinese
-
Abstract:
A case with mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency(HMGCSD)was related and foreign and domestic reported cases were reviewed.The female proband was 7 months and 16 days old, and admitted to the hospital due to acute onset of " fever for 4 days, wheezing for 3 hours, dyspnea and moaning for 2 hours" . She was mainly manifested as encephalopathy, hepatomegaly, liver function damage, low ketone hypoglycemia, and hyperlipidemia.She died of respiratory and circulatory failure on the third day of hospitalization.Two compound he-terozygous variants in HMGCS2 gene were found by total exome sequencing, namely, c.1061+ 1 G> C and c. 476 G> T. HMGCSD could be diagnosed by gene detection in combination with clinical features of the patient. Thirteen literatures related to HMGCSD were collected, including 26 patients in total, with the age of onset ranging from 3 months to 6 years. The main cause of the disease was insufficient intake, mainly manifested as hypoglycemia accompanied by low ketone, hepatomegaly, liver damage, etc. A high level of urinary 4- hydroxy-6- methyl-2- pyrone might be a strong indicator of HMGCSD. Three died during the acute attack. Up to now, there were 32 mutations in HMGCS2 reported in 26 patients, and the main type was missense mutation. In this article, the second case of HMGCSD in China was identified, and 2 novel variants of HMGCS2 were found, which extended the clinical phenotype and mutation spectrum of HMGCSD.
